A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma
- 7 February 2018
- journal article
- research article
- Published by Elsevier BV in European Urology Focus
- Vol. 4 (6), 995-1001
- https://doi.org/10.1016/j.euf.2018.01.015
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Guía clínica sobre el cáncer de testículo de la EAU: actualización de 2011Actas Españolas de Psiquiatría, 2012
- Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy SurgeryJournal of Clinical Oncology, 2010
- Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Testicular Cancer: Radical or Modified Template ResectionEuropean Urology, 2009
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part IEuropean Urology, 2008
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part IIEuropean Urology, 2008
- Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancerInternational Journal of Urology, 2004
- Prediction of Necrosis After Chemotherapy of Advanced Germ Cell Tumors: Results of a Prospective Multicenter Trial of the German Testicular Cancer Study GroupJournal of Urology, 2004
- Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor MassesJournal of Clinical Oncology, 2003
- The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: Current concepts and controversiesSeminars in Urologic Oncology, 2002
- VALIDATION OF A PREDICTION MODEL AND ITS PREDICTORS FOR THE HISTOLOGY OF RESIDUAL MASSES IN NONSEMINOMATOUS TESTICULAR CANCERJournal of Urology, 2001